Two Distinct Immune Cell Signatures Predict the Clinical Outcomes in Patients With Amyopathic Dermatomyositis With Interstitial Lung Disease
Yan Ye(Anhui Medical University), Xiaoming Zhang(Institute of Infection and Immunity), Chunde Bao(Renji Hospital), Shuang Ye(Renji Hospital), Qiong Fu(Renji Hospital), Runci Wang(Brigham and Women's Hospital), Teng Li(Institut Pasteur of Shanghai), Ran Wang(Renji Hospital), Xueliang Zhang(Chinese PLA General Hospital), Chunmei Wu(Renji Hospital), Jiaqiang Ma(National University of Defense Technology), Qiang Guo(Renji Hospital), Nan Shen(Cincinnati Children's Hospital Medical Center)
Cited by 29
Related Papers
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
|Nature Medicine|2016|570
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma
|Nature Metabolism|2023|540
PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
|Journal for ImmunoTherapy of Cancer|2019|387
Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma
|Journal of Hepatology|2021|245